Similar articles

• Immunotherapy from malignant disease.

  Goodnight JE Jr, Morton DL. Goodnight JE Jr, et al. Annu Rev Med. 1978;29:231-83. doi: 10.1146/annurev.me.29.020178.001311. Annu Rev Med. 1978. PMID: 348035 Review. No abstract available.
• [The current status of chemo- or immunotherapy of gastrointestinal tumors].

  Schmidt M, Gropp C, Martini GA. Schmidt M, et al. Internist (Berl). 1978 Dec;19(12):692-9. Internist (Berl). 1978. PMID: 217849 German. No abstract available.
• [Immunotherapy of lung cancer].

  Jassem J, Jassem E. Jassem J, et al. Pol Tyg Lek. 1982 Jun 14;37(17):497-9. Pol Tyg Lek. 1982. PMID: 6292882 Review. Polish. No abstract available.
• Active non-specific immunotherapy of experimental tumours.

  Silobrcić V. Silobrcić V. Folia Biol (Praha). 1980;26(3):145-66. Folia Biol (Praha). 1980. PMID: 6998756 Review. No abstract available.
• [Initial experiences with a nation-wide Austrian study of adjuvant chemo- and immunotherapy of colorectal cancer following radical surgery].

  Karrer K, Denck H, Pridun N. Karrer K, et al. Acta Med Austriaca Suppl. 1979;6:325-6. Acta Med Austriaca Suppl. 1979. PMID: 299221 Clinical Trial. German.